Melanoma Clinical Trials

Showing 301-320 of 1,477 trials

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

NCT07183852

The purpose of this study is to evaluate the feasibility, safety and tolerability of locoregional or systemic administration of autologous tumor infiltrating lymphocytes in patients with metastatic melanoma

Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma

Vastra Gotaland Region18 participantsStarted Mar 2026

COMPLETEDPhase 1

A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma

NCT04640545

A phase I clinical study evaluating LBL-007 in the treatment of subjects with advanced solid tumors

Advanced Melanoma

Nanjing Leads Biolabs Co.,Ltd79 participantsStarted May 2020

Beijing, Beijing Municipality, China • Fuzhou, Fujian, China • Wuhan, Hubei, China +5 more locations

RECRUITING

Personalised Immunotherapy Platform

NCT06536257

This is a non-interventional study to prospectively test a suite of predictive biomarker models of immunotherapy resistance in patients with melanoma, non-melanoma skin cancers and other solid tumours. The study will evaluate the documentation, processes, accuracy and utility of the predictive biomarker model in clinical practice.

MelanomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+2 more

Melanoma Institute Australia1,000 participantsStarted Jun 2021

Sydney, New South Wales, Australia • Sydney, New South Wales, Australia • Sydney, New South Wales, Australia

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma

Personalised Immunotherapy Platform

Related Searches

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies

Melphalan Chemoreduction for Ocular Melanoma

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Combination Immunotherapy Targeting Melanoma

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risk

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

AMT-253 in Patients With Advanced Solid Tumours

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

Educational Intervention on Skin Cancer Protective Behaviors Among Female Healthcare Workers

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)